» Articles » PMID: 16477172

The Independent Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiovascular Risk Factors in Humans

Overview
Specialty General Medicine
Date 2006 Feb 16
PMID 16477172
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This review details the independent effects of purified eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. We report data from the recent literature and our own controlled clinical trials which compared the independent effects of these fatty acids in individuals at increased risk of cardiovascular disease, namely overweight hyperlipidaemic men and treated-hypertensive, type 2 diabetic men and women. We discuss the biological effects of these fatty acids and the potential mechanisms through which they may affect cardiovascular disease risk factors.

Recent Findings: A cardioprotective effect for omega3 fatty acids is supported by prospective studies demonstrating an inverse association between fish intake and coronary heart disease mortality. Data from secondary prevention trials support a reduction in ventricular fibrillation as a primary mechanism for the decreased incidence of myocardial infarction. Clinical trials and experimental studies have shown that omega3 fatty acids have many other potentially important antiatherogenic and antithrombotic effects. Omega-3 fatty acids lower blood pressure and heart rate, improve dyslipidaemia, reduce inflammation, and improve vascular and platelet function. These favourable effects have until recently been primarily attributed to the omega3 fatty acid eicosapentaenoic acid, which is present in large amounts in fish oil. Controlled studies in humans now demonstrate that docosahexaenoic acid, although often present in lower quantities, has equally important anti-arrhythmic, anti-thrombotic and anti-atherogenic effects.

Summary: Available evidence strongly suggests that eicosapentaenoic acid and docosahexaenoic acid have differing haemodynamic and anti-atherogenic properties. The effects of the two fatty acids may also differ depending on the target population.

Citing Articles

Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer's disease.

Oye Mintsa Mi-Mba M, Lebbadi M, Alata W, Julien C, Emond V, Tremblay C J Lipid Res. 2024; 65(12):100682.

PMID: 39490923 PMC: 11650307. DOI: 10.1016/j.jlr.2024.100682.


Placental AA/EPA Ratio Is Associated with Obesity Risk Parameters in the Offspring at 6 Years of Age.

Gomez-Vilarrubla A, Mas-Pares B, Carreras-Badosa G, Jove M, Berdun R, Bonmati-Santane A Int J Mol Sci. 2023; 24(12).

PMID: 37373236 PMC: 10298678. DOI: 10.3390/ijms241210087.


Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials.

Wang T, Zhang X, Zhou N, Shen Y, Li B, Chen B J Am Heart Assoc. 2023; 12(11):e029512.

PMID: 37264945 PMC: 10381976. DOI: 10.1161/JAHA.123.029512.


Intake of residuals from Atlantic cod attenuated blood pressure increase but did not delay development of kidney damage in obese Zucker fa/fa rats.

Vildmyren I, Oterhals A, Leh S, Samuelsen T, Halstensen A, Marti H Food Nutr Res. 2022; 66.

PMID: 36340918 PMC: 9602205. DOI: 10.29219/fnr.v66.8708.


Health Benefits, Food Applications, and Sustainability of Microalgae-Derived N-3 PUFA.

Liu Y, Ren X, Fan C, Wu W, Zhang W, Wang Y Foods. 2022; 11(13).

PMID: 35804698 PMC: 9265382. DOI: 10.3390/foods11131883.